DSpace university logo mark
詳細検索
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 030 医学部 > 030 紀要 > Acta Medica Nagasakiensia > Volume 59, No. 2 >

Life-threatening toxicity in a patient with UGT1A1*6 heterozygous polymorphism after irinotecan-based chemotherapy: a case report


ファイル 記述 サイズフォーマット
ActMed59_63.pdf447.48 kBAdobe PDF本文ファイル

タイトル: Life-threatening toxicity in a patient with UGT1A1*6 heterozygous polymorphism after irinotecan-based chemotherapy: a case report
著者: Ogawara, Daiki / Fukuda, Minoru / Nakamura, Yoichi / Nakatomi, Katsumi / Motoshima, Kohei / Senju, Hiroaki / Mizoguchi, Kousuke / Takemoto, Shinnosuke / Honda, Takuya / Ashizawa, Kazuto / Hasegawa, Yoshinori / Kohno, Shigeru
発行日: 2014年12月
出版者: Nagasaki University School of Medicine / 長崎大学医学部
引用: Acta medica Nagasakiensia, 59(2), pp.63-65; 2014
抄録: Polymorphism of the UGT1A1 gene is known to play an important role in irinotecan pharmacokinetics and severe toxicity. A 71-year-old man with lung cancer (squamous cell carcinoma cT2aN3M0 stage IIIB) received irinotecan and cisplatin with concurrent thoracic radiotherapy. Although all treatments were discontinued after day 7, severe leukopenia, neutropenia, febrile neutropenia, thrombocytopenia, and diarrhea developed. His life was at risk, and his ECOG performance status (PS) fell to 4. He had UGT1A1*6 heterozygous and UGT1A1*28 wild-type gene polymorphisms. Considering its frequency in Asians, we should take care when using irinotecan to treat patients with UGT1A1*6 heterozygous polymorphism.
キーワード: UGT1A1*6 polymorphism / irinotecan / lung cancer
URI: http://hdl.handle.net/10069/34980
ISSN: 00016055
資料タイプ: Departmental Bulletin Paper
原稿種類: publisher
出現コレクション:Volume 59, No. 2

引用URI : http://hdl.handle.net/10069/34980

このリポジトリに保管されている文献はすべて著作権により保護されています。
印刷やダウンロード等データの複製は、調査研究・教育または学習を目的とする場合に限定されます。

 

Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace